Fujian Wanchen Biotechnology Co. Ltd (300972) - Total Liabilities

Latest as of March 2026: CN¥7.34 Billion CNY ≈ $1.07 Billion USD

Based on the latest financial reports, Fujian Wanchen Biotechnology Co. Ltd (300972) has total liabilities worth CN¥7.34 Billion CNY (≈ $1.07 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Fujian Wanchen Biotechnology Co. Ltd (300972) equity growth momentum to track the company's year-over-year net asset growth rate.

Fujian Wanchen Biotechnology Co. Ltd - Total Liabilities Trend (2019–2025)

This chart illustrates how Fujian Wanchen Biotechnology Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300972 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Fujian Wanchen Biotechnology Co. Ltd Competitors by Total Liabilities

The table below lists competitors of Fujian Wanchen Biotechnology Co. Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Compagnie du Cambodge PA:CBDG	France	€104.90 Million
Cogent Biosciences Inc NASDAQ:COGT	USA	$301.24 Million
Glanbia PLC IR:GL9	Ireland	€2.05 Billion
Ameris Bancorp NYSE:ABCB	USA	$24.03 Billion
Motiva Infraestrutura de Mobilidade S.A. SA:MOTV3	Brazil	R$59.38 Billion
QMMM Holdings Limited Ordinary Shares NASDAQ:QMMM	USA	$71.22K
Capital Financial Indonesia Tbk PT JK:CASA	Indonesia	Rp24.51 Trillion
Marfrig Global Foods S.A. SA:MRFG3	Brazil	R$122.53 Billion

Liability Composition Analysis (2019–2025)

This chart breaks down Fujian Wanchen Biotechnology Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Fujian Wanchen Biotechnology Co. Ltd (300972) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.55	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	3.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fujian Wanchen Biotechnology Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)

The table below shows the annual total liabilities of Fujian Wanchen Biotechnology Co. Ltd from 2019 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥7.50 Billion ≈ $1.10 Billion	+29.43%
2024-12-31	CN¥5.79 Billion ≈ $847.56 Million	+79.35%
2023-12-31	CN¥3.23 Billion ≈ $472.58 Million	+510.75%
2022-12-31	CN¥528.79 Million ≈ $77.38 Million	+151.24%
2021-12-31	CN¥210.47 Million ≈ $30.80 Million	-18.40%
2020-12-31	CN¥257.94 Million ≈ $37.74 Million	-17.01%
2019-12-31	CN¥310.81 Million ≈ $45.48 Million	--

About Fujian Wanchen Biotechnology Co. Ltd

SHE:300972 China Farm Products

Market Cap

$5.85 Billion

CN¥39.97 Billion CNY

Market Cap Rank

#3205 Global

#408 in China

Share Price

CN¥205.81

Change (1 day)

-5.81%

52-Week Range

CN¥145.78 - CN¥232.89

All Time High

CN¥232.89